求人・転職情報

Working with the Head of DSPV-Japan, this role is responsible for ensuring optimal patient safety as first priority by developing a state-of-the-art safety strategy, driving medical safety processes and capabilities and having accountability for safety compliance in Japan.

Basic purpose of the job

Based on sound medical knowledge, this role defines the local Patient Safety & Pharmacovigilance (PSPV) strategy not aonly for the delegated asset (AT) but also other products as needed and ensures the consistent implementation of the BI risk mitigation strategy to safeguard patients and / or clinical trial subjects by providing benefit/risk (B/R) expertise to the cross-functional teams based on the framework provided by Global PSPV .
Together with the LPSL, the local Patient Safety Physician (PSP) ensures by contributing to the local PSPV strategy and by responsibly taking care of delegated parts of the local PSPV system to establish and maintain a high-quality local PSPV system which is compliant with external regulations and internal processes.

Accountabilities
As an expert of benefit/risk (B/R) profile, which are assessed by global BR team and aligned among global and local, engage to take safety assurance measures such as preparation of J-RMP, proper use of drugs and closely work with evidence/asset team by providing B/R knowledge and work with global team by inputting local needs/insight.
ž -Lead to prepare local Risk management Plans in response to Japanese specific requirements (e.g. country-specific format) and content in liaison with GPV functions.
ž -Implementation and progress of global risk minimization measures, lead to prepare local RMP development and implementation not only for the delegated asset (AT) but also other products as needed. Provide PV input and insights to local labelling documents and educational materials (e.g. SPC, PIL) in time and quality.
ž -Perform local safety data monitoring not only for the delegated asset (AT) but also other products as needed. Timely information of the respective PVWG Chairperson on any relevant new safety information received from local sources for BI products or for products of the same class.
ž -Promote implementation of safety assurance measure such as proper use of drug, including preparation of guidelines for them in collaboration with stakeholders (e.g.LRA, legal &complaince)
ž -Perform Medical Quality Review of all fatal / life-threatening cases as needed and defines appropriate follow-up measures. Complete ‘fatal case investigation’ report as needed.

Manage health authority requests, potential safety issues and / or crisis management not only for the delegated asset (AT) but also other products as needed and together with global/local stakeholders.

Contribute to the PSPV Culture, Local PSPV Strategy & the establishment and maintenance of a high-quality local PSPV system, Review controlled documents (e.g. PV Working Instruction, PV Repository, applicable sections in PSMF annexes, local SOPs, etc.) also contribute to Japan initiatives to promote Patient Safety & Pharmacovigilance concepts and conduct PV trainings, where the training needs were identified, for internal and external customers.

To be ready for inspection and support to management of non-compliance
-Reporting of non-compliances as soon as becomes aware of the issue and Contribute to investigate non-compliances and associated CAPA (Corrective and Preventive Actions) activities. Take over CAPA Lead Function, if required.
-Establish and support local inspection readiness, participate in PV audits and PV/GPSP/GCP inspections.

Support the implementation activities to enhance PV compliance culture and PV awareness at local level of the organization in line with global recommendations

Proactively cooperation with Global PSPV on any upcoming new regulations or BI processes to assess the local impact and their implementation within the team.
-Contribute to seting up/optimizing of local PSPV processes including the takeover of subtasks e.g. creation/revision of the related documentation (Standard Operating Procedures (SOPs), Local PV System Framework, KMed Assets, etc.)

Regulatory and / or Organisational Requirements

Excellent knowledge of applicable global, regional and local PV regulations, BI processes and relevant GxP requirements.
Be compliant and acts within ethics at all times.

Job Complexity
The position requires extensive regulatory,scientific knowledge and balanced risk-based decision making. This needs to take into account needs and requirements of other functions, departments and units.

Interfaces
Local Medical Director, Global Patient Safety & Pharmacovigilance, MSG,CDMAs, LRA, MKT, SL, RWD
GRA, CD&O

主な業務は、臨床試験の安全報告管理、NDA関連のリスク管理計画作成、PMDA対応、市販後の安全対策実施、PVシステム運用管理、チームの育成とリソース配分です。患者安全とコンプライアンス重視の文化醸成も担います。

当日本ファーマコエピデミオロジーチームは、地域横断型の安全性監視部門です。全世界に展開する参天製品や治験品の安全性を戦略的に監視する役割を果たしています。

＜ポジションの役割/PR＞
People centricityのマインドセットの下、当部門が保有する豊富な安全性・有効性データを活用し、規制対応を越えて、医療現場の医師・患者さんに安心と信頼を届けるための積極的な情報発信をリードして頂きます。


JOB DESCRIPTION
【業務内容】
・自社製品（医薬品及び医療機器）の安全性に関わる事項について、開発相及び市販後におけるカンパニーポジションを構築する。
・安全監視活動を効果的に実施するために、メディカルエバリュエーション、コンプライアンス、オペレーションの各機能と連携する。
・様々な研究データを活用して医薬品・医療機器の安全性・有効性を分析する薬剤疫学的アプローチにより、開発相及び市販後において、自社製品のベネフィット・リスクバランスを評価する。
・医学的、科学的バックグラウンドとスキルを活用し、自社製品の適正使用を促進する。
・安全性に関わる戦略を構築し、潜在的なSafety issueを特定し、適切な安全性監視活動を計画、実行する。
・RMP、PSUR、DSUR、CCDSの安全性パートなど、安全性に関わるグローバル文書十分な品質のもと作成し、遅滞なく各規制当局へ提出されていることを監督する。
学会発表、論文等のpublicationを主導する。
・GSVEM (Global Safety Vigilance Evaluation Meeting)を主宰し、安全性に関わるトピックについて、高質かつ適時の提案がなされるようサポートする。
・ファーマコエピデミオロジーグループが主管する製造販売後調査の計画、実行、完了を監督する。
・安全性シグナル、社外リアルワールドデータ等の外部データソース探索に関連する安全性監視活動の標準業務手順書（SOP）を作成、レビュー、アップデートし、規制変更に対応する。
・安全性監視の全般プロセス、方針、手順の更なる改善に向けて意見具申する。
・安全性監視システムに関わる内外の査察及び査察後対応に参画し、不適合事項に対処し、CAPAを効果的に立案、実行を保証する。

■職務内容
Description:
The PS Epidemiologist (PSEPI) serves as a study lead for Post Authorization Regulatory Commitment Studies (PARCS) including post-marketing database study and use-result survey, accelerating the generation of valuable real-world evidence. Leveraging extensive clinical research expertise, including secondary data analysis, as well as various data assets and access rights held by AZKK, the PSEPI is responsible for the methodological reliability and scientific robustness at all stages of responsible research, from study planning and execution to study completion and publication. As an expert in epidemiological research, the PSEPI leads the education and utilization of real-world data within the Japan Patient Safety organization and contributes to organizational development.

Accountabilities/Responsibilities:
Strategic Evidence Planning
PSEPI contributes to the development of local Risk Management Plans (RMPs) preparing by Japan Patient Safety (PS). They start planning formulate Pharmacovigilance Plan (PVP) strategies and PARCS from the preparation stage of the new drug application (NDA) and lead discussions and consensus-building with internal stakeholders and regulatory authorities regarding PVP strategies for NDAs.

Study Execution
PSEPI creates study design concepts (SDC) and clinical study protocols (CSP) based on PVP strategies as the scientific lead for PARCS. They conduct feasibility assessments for PARCS and lead the technical review and approval of SDC/CSPs within the global governance related to evidence generation. In study execution and publicizing study results, the PSEPI leads regulatory processes, including epidemiological consultations, and engages with internal and external stakeholders. They oversee the execution of the analysis plan and the preparation of interim and final reports with study team members, ensuring quality by reviewing deliverables. They also support the planning and execution of external presentations and publication.

Leading team as an epidemiologist
In team working, the PSEPI serves as the leader of cross-functional study teams, leveraging members' expertise to ensure the successful execution of study activities. They provide coaching to study team members to support and accelerate their performance and facilitate smooth collaboration with cross-functional company-wide teams as a representative of Japan Patient Safety. As a skills leader, the PSEPI contributes to enhancing the real-world evidence (RWE) generation capabilities of PS Epidemiology & Evidence Generation members. They monitor changes in the external environment related to epidemiological research methodologies, available information sources, research-related technological trends, regulatory trends, and guidance on evidence generation in therapeutic areas, and lead the continuous improvement of deliverable quality by integrating these changes into company processes.

・各GxP領域を横断したグローバルQMSガバナンス体制の設計、構築および継続的改善の推進
・グローバル品質指標（Quality Metrics / KPIs）の確立、運用および改善を通じたQMS運用状況のモニタリング
・品質データの定義、収集およびデータ品質管理（Data Quality Management）の仕組みの整備
・品質データの可視化基盤（BIツール等）の整備および活用推進
・品質データの分析に基づく品質課題の特定および改善活動の推進
・グローバル品質マネジメントレビューの企画、運営および継続的改善

・安全性部門やグローバルの疫学と協業してRQを設定する。
・RWD分析（DBをデータソースとし、RQに応じたデータセット構築・解析を行う
・Literature Review：必要に応じSysteamatic Literature Reviewを実施したりMata Analysisを実施する場合もある。
・製造販売後調査業務

以下の安全対策業務をリード
・海外の安全対策担当者と協働したグローバル安全対策業務（安全性モニタリング、安全対策の検討など）
・治験の安全性モニタリング
・承認申請、照会事項対応
・市販後安全対策
・上記内容に関するプロセス検討、改善策立案等

・グローバル安全性データベースおよび周辺システム・ツールの運用管理業務
・グローバルでの新規システム・ツールの導入業務
・グローバルでのシステム・ツール管理チーム調整業務
・海外システム管理ベンダーとの調整業務
・新技術（RPA、AI）等の導入検討業務"

症例評価プロセスのグローバルハーモナイズ、プロセス自動化のプロジェクトリード等

●グローバルリードとして、グローバル安全管理ユニットの業務品質のモニタリング、継続改善業務、PV業務品質管理体制の基盤構築業務を推進する
●グローバルリードとして、国内/海外の規制当局や提携会社、自社監査部門等によるPV関連の査察・監査の対応や査察・監査対応業務の基盤構築業務を推進する

・グローバルPVの渉外管理担当
・グローバルPV契約の締結・維持・管理
・グローバルPV-SOPの維持・管理
・海外子会社・海外提携会社と連携し、グローバルPV systemの維持・管理・改善の推進

●グローバルPV企画・管理業務
●安全管理業務に関わるBusiness Excellence/プロジェクトの戦略的な計画立案・推進支援

Global CSPV Unitの運営体制の構築・推進にあたり中心的な役割を担う。部門横断的な課題解決にあたり中心的な役割を担い、部門間連携を促進しUnit目標の達成を支援する。、Unitの人員管理、予算管理、会議体運営、リスクマネジメントに関して、所属上長と連携して実装することにより、Unit全体のパフォーマンス向上及び業務効率化を図る。

仕事内容：
自社開発品の早期臨床開発における安全性管理を担当し、グローバルな医薬品開発に貢献する。

Background of recruitment：
To strengthen the safety function in early clinical development.

As Regulatory Affairs country manager, to ensure that regulatory submissions and post-licensing compliance are executed for all products according to the local law; to coordinate the activities necessary to achieve and maintain appropriate permits, licenses and other documentation required to be in compliance with appropriate regulatory authorities

・治験・市販後の安全性情報評価、シグナル・リスク管理、措置立案・実施
・各種安全性定期報告書（DUSRを含む）の作成
・安全性情報収集・管理システムの運用
・安全性情報に関する国内外提携会社との連携業務

The role manages comprehensive Pharmacovigilance (PV) activities in Japan, ensuring full compliance with global and local regulations such as GCP, GVP, GPSP, and J-PAL. It includes supporting and substituting for the Safety Contact Person as needed. Key responsibilities encompass collecting, evaluating, and finalizing safety information and reports within regulatory timelines, managing Pharmacovigilance Agreements with external vendors, and providing safety information to stakeholders.
The role involves planning and executing Risk Management Plans (RMPs), post-marketing surveillance (PMS), and risk minimization activities, including development of guidebooks for healthcare professionals and patients. It also covers managing domestic GVP/GPSP standard operating procedures (SOPs), conducting training and audits to maintain readiness, ensuring electronic record retention, and collaborating closely with regulatory authorities such as MHLW and PMDA, as well as internal teams across Regulatory Affairs, Commercial, and R&D.
Furthermore, The role collaborates with global PV teams to support activities like Pharmacovigilance System Master File (PSMF) updates and compliance with EMA regulations. Proactive management of new product integration into PV systems and undertaking special tasks as assigned are also essential components of the role.